Slingshot Insights | Mkgay Overview

MKGAY Overview

Upcoming Projects (MKGAY)

Don’t see a project related to the company you care about? Create your own!

Upcoming & Overdue Catalysts (MKGAY)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (MKGAY)

PDUFA Date of August 27 for Merck KGaA's (MKGAY) Biologics License Application for Avelumab in Treatment of Metastatic Urothelial Carcinoma With Disease Progression on or After Platinum-Based Chemotherapy
Tickers: MKGAY, MRK, EMD Serono
Occurred on: May 09, 2017

Strategic Initiatives (MKGAY)

Vertex (VRTX) and Merck KgaA (MKGAY) Announce Collaboration and License Agreement Covering Four Oncology R&D Programs
Tickers: MRK, VRTX, MKGAY
Announcement Date: Jan 11, 2017
HTG Molecular (HTGM) Agrees to Develop Companion Diagnostic Tests for Merck KGaA's (MKGAY) Cancer Candidates
Tickers: HTGM, MRK, MKGAY
Announcement Date: Oct 11, 2016